InvestorsHub Logo
icon url

Solantey

12/16/12 1:39 PM

#21512 RE: vegasvic #21504

There are a myriad of opportunities for Amarantus Bioscience moving forward.

This is so undervalued currently that I almost feel like I'm stealing shares every time I buy a few more.

"Big pharma" development partnership takes it above $1.00 in 2013.


















icon url

cjstocksup

12/16/12 7:03 PM

#21558 RE: vegasvic #21504

You have connected the dot's perfectly on Banyon and their gov. grant for almost 30 million dollars and AMBS working with Banyon and our TBI drug. The potential for the shareholders here is massive.

PLEASE READ DIFFERENT PERSPECTIVE THAT NO ONE DISCUSES HERE.....

If u read my post about Banyan Biomarkers they are getting govt. grants for developing a test for TBI.

How much is the govt. willing to pay for a medical solution for treatment of TBI.

ANSWER... A LOT MORE.

GRANTS COMING. I BELIEVE THE REAL STORY WITH AMBS IS TBI
WITH ALL THE TRAUMA CASES EVERY DAY NFL...ALL SPORTS...AUTO ACCIDENTS..AND SO ON.

TBI & BANYAN ARE THE LEADERS IN THE FIELD FOR TBI & THEY JUST
HAPPEN TO BE WORKING TOGETHER.

THIS IS GONNA HAPPEN A LOT SOONER THAN PARKINSONS.

AMBS IS BUILDING A COMPANY EQUAL TO AMGEN OR BIGGER IN BIO TECH

BUT IF YOU DONT HAVE THE CEO'S VISION U LOSE.